Patents by Inventor Polo Chun-Hung LAM

Polo Chun-Hung LAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS HAVING ((3-NITROPHENYL)SULFONYL)ACETAMIDE AS BCL-2 INHIBITORS
    Publication number: 20240043424
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I):
    Type: Application
    Filed: September 12, 2023
    Publication date: February 8, 2024
    Applicant: Eil Therapeutics, Inc.
    Inventors: Volodymyr Kysil, Vladislav Zenonovich Parchinsky, Alexei Pushechnikov, Alexandre Vasilievich Ivachtchenko, Ruben Abagyan, Andrew Orry, Polo Chun-Hung Lam, Nikolay Savchuk
  • Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors
    Patent number: 11834450
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I):
    Type: Grant
    Filed: March 18, 2022
    Date of Patent: December 5, 2023
    Assignee: EIL THERAPEUTICS, INC.
    Inventors: Volodymyr Kysil, Vladislav Zenonovich Parchinsky, Alexei Pushechnikov, Alexandre Vasilievich Ivachtchenko, Ruben Abagyan, Andrew Orry, Polo Chun-Hung Lam, Nikolay Savchuk
  • COMPOUNDS HAVING ((3-NITROPHENYL)SULFONYL)ACETAMIDE AS BCL-2 INHIBITORS
    Publication number: 20230357238
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (A):
    Type: Application
    Filed: July 14, 2023
    Publication date: November 9, 2023
    Applicant: Eil Therapeutics, Inc.
    Inventors: Volodymyr KYSIL, Vladislav Zenonovich PARCHINSKY, Alexei PUSHECHNIKOV, Alexandre Vasilievich IVACHTCHENKO, Ruben ABAGYAN, Andrew ORRY, Polo Chun-Hung LAM, Nikolay SAVCHUK
  • Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors
    Patent number: 11697650
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I):
    Type: Grant
    Filed: March 11, 2022
    Date of Patent: July 11, 2023
    Assignee: Eil Therapeutics, Inc.
    Inventors: Volodymyr Kysil, Vladislav Zenonovich Parchinsky, Alexei Pushechnikov, Alexandre Vasilievich Ivachtchenko, Ruben Abagyan, Andrew Orry, Polo Chun-Hung Lam, Nikolay Savchuk
  • COMPOUNDS HAVING ((3-NITROPHENYL)SULFONYL)ACETAMIDE AS BCL-2 INHIBITORS
    Publication number: 20220306625
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I):
    Type: Application
    Filed: March 18, 2022
    Publication date: September 29, 2022
    Inventors: Volodymyr KYSIL, Vladislav Zenonovich PARCHINSKY, Alexei PUSHECHNIKOV, Alexandre Vasilievich IVACHTCHENKO, Ruben ABAGYAN, Andrew ORRY, Polo Chun-Hung LAM, Nikolay SAVCHUK
  • COMPOUNDS HAVING TETRAHYDROINDOLIZINE-1-CARBOXAMIDE AS BCL-2 INHIBITORS
    Publication number: 20220289745
    Abstract: The present invention is generally directed to inhibitors of BCL-2 proteins useful in the treatment of diseases and disorders modulated by said enzyme and having the Formula (I):
    Type: Application
    Filed: March 11, 2022
    Publication date: September 15, 2022
    Inventors: Volodymyr KYSIL, Vladislav Zenonovich PARCHINSKY, Alexei PUSHECHNIKOV, Alexandre Vasilievich IVACHTCHENKO, Ruben ABAGYAN, Andrew ORRY, Polo Chun-Hung LAM, Nikolay SAVCHUK